[Corrigendum] ENO2 affects the EMT process of renal cell carcinoma and participates in the regulation of the immune micro­environment

Chen,Wei-Jie; Yang,Wei; Gong,Min; He,Yi; Xu,Da; Chen,Jia-Xin; Chen,Wen-Jin; Li,Wen-Yan; Wang,Yu-Qi; Dong,Ke-Qin; Song,Xu; Pan,Xiu-Wu; Cui,Xin-Gang

doi:10.3892/or.2026.9135

July-2026 Volume 56 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

July-2026 Volume 56 Issue 1

Full Size Image

Correction Open Access

[Corrigendum] ENO2 affects the EMT process of renal cell carcinoma and participates in the regulation of the immune microenvironment

Authors:
- Wei-Jie Chen
- Wei Yang
- Min Gong
- Yi He
- Da Xu
- Jia-Xin Chen
- Wen-Jin Chen
- Wen-Yan Li
- Yu-Qi Wang
- Ke-Qin Dong
- Xu Song
- Xiu-Wu Pan
- Xin-Gang Cui
View Affiliations / Copyright

Affiliations: Department of Urology, Third Affiliated Hospital of The Second Military Medical University, Shanghai 200433, P.R. China, Department of Urology, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai 200137, P.R. China, Department of Urology, Jiaxing First Hospital, Jiaxing, Zhejiang 314001, P.R. China, Department of Urology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, P.R. China

Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article Number: 130
|
Published online on: May 13, 2026

https://doi.org/10.3892/or.2026.9135
Expand metrics +

Article

Oncol Rep 49: [Related article:] 33, 2023; DOI: 10.3892/or.2022.8470

Following the publication of this article, the authors have brought to the Editor's attention that they made an error in the compilation of the data in Fig. 4, as it appeared on p. 9. Specifically, some of the blots included for the 769-P cell line experiments in Fig. 4B had inadvertently been included in the figure incorrectly.

Figure 4.

In vitro experiments demonstrating that ENO2 knockdown inhibits EMT and ccRCC progression. (A) The mRNA expression levels of ENO2 in HK2 and RCC cells (Caki-1, ACHN, A498, 786-O and 769-P) were detected using reverse transcription-quantitative PCR analysis. (B and C) Western blotting demonstrated that ENO2 expression was effective2ly knocked down in (B) 769-P and (C) ACHN cells. The altered expression levels of the proteins VIM and N-cadherin suggested that ENO2 knockdown was able to prevent the EMT process of RCC. (D and E) Proliferation of (D) 769-P and (E) ACHN cells transfected with control and shENO2 vectors was determined using Cell Counting Kit-8 assays. (F and G) Two sets of RCC cells (control and shENO2) were tested for their capacity to (A) migrate using Transwell assay analysis and (B) invade using Matrigel assay analysis. Scale bar, 100 µm. *P<0.05 and ***P<0.001. ENO2, enolase 2; EMT, epithelial-mesenchymal transition; ccRCC, clear cell renal cell carcinoma; VIM, vimentin..

The corrected version of Fig. 4, now showing all the correct western blot data in Fig. 4B, is shown on the next page. The authors sincerely apologize for the errors that were introduced during the preparation of this figure, and are grateful to the Editor of Oncology Reports for granting them the opportunity to publish a Corrigendum. All the authors agree with the publication of this Corrigendum, and they also regret any inconvenience that this mistake may have caused.

Journals